Glen M Boyle Selected Research

Ligands

10/2019

C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glen M Boyle Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 04/2004
32	Melanoma (Melanoma, Malignant) 01/2023 - 06/2005
7	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2005
5	Squamous Cell Carcinoma of Head and Neck 01/2019 - 02/2005
4	Necrosis 04/2024 - 04/2004
4	Carcinogenesis 10/2019 - 08/2007
4	Breast Neoplasms (Breast Cancer) 04/2018 - 10/2010
4	Skin Neoplasms (Skin Cancer) 01/2016 - 04/2004
3	Infections 01/2022 - 09/2011
3	Inflammation (Inflammations) 03/2016 - 01/2011
2	Wounds and Injuries (Trauma) 01/2022 - 01/2020
2	Malaria 10/2016 - 09/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2015 - 04/2014
2	Erythema 01/2014 - 02/2003
2	Ascites 01/2013 - 04/2010
2	Ovarian Epithelial Carcinoma 01/2013 - 04/2010
1	Hypersensitivity (Allergy) 04/2023
1	Skin Diseases (Skin Disease) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Schistosomiasis (Bilharziasis) 11/2020
1	Human Influenza (Influenza) 10/2019
1	Chagas Disease (American Trypanosomiasis) 01/2019
1	Echinococcosis (Hydatid Cysts) 01/2018

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2006
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2002
5	Protein Kinase CIBA 04/2024 - 10/2006
5	CytokinesIBA 01/2022 - 02/2009
5	Messenger RNA (mRNA)IBA 10/2019 - 02/2003
5	DiterpenesIBA 01/2019 - 04/2004
5	EstersIBA 01/2019 - 04/2004
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
4	MicroRNAs (MicroRNA)IBA 08/2016 - 03/2010
3	PhorbolsIBA 01/2022 - 01/2020
3	ChemokinesIBA 01/2022 - 10/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 06/2004
3	3-ingenyl angelateIBA 01/2016 - 04/2004
3	Histones (Histone)IBA 12/2006 - 06/2004
2	Adenosine Triphosphate (ATP)IBA 04/2024 - 10/2022
2	CaspasesIBA 04/2024 - 06/2005
2	Peptides (Polypeptides)IBA 01/2023 - 10/2022
2	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2013
2	Protein Isoforms (Isoforms)IBA 01/2021 - 03/2015
2	Phosphotransferases (Kinase)IBA 11/2020 - 08/2014
2	Phorbol EstersIBA 10/2020 - 10/2006
2	EBC-46IBA 01/2020 - 01/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2019 - 01/2018
2	ChromatinIBA 02/2017 - 06/2005
2	Microphthalmia-Associated Transcription FactorIBA 01/2017 - 11/2011
2	Interferon Type IIBA 10/2016 - 09/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2015 - 04/2014
2	Cadherins (E-Cadherin)IBA 08/2014 - 06/2009
2	H-cadherin (T-cadherin)IBA 08/2014 - 06/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 04/2010
2	Mitogen-Activated Protein KinasesIBA 10/2010 - 10/2006
2	Cytostatic AgentsIBA 10/2010 - 10/2006
2	Small Interfering RNA (siRNA)IBA 04/2009 - 02/2009
2	Histone Deacetylases (Histone Deacetylase)IBA 12/2006 - 06/2005
2	ParaffinIBA 07/2005 - 02/2005
2	Histone Deacetylase InhibitorsIBA 06/2005 - 06/2004
1	HMGB1 Protein (HMG1)IBA 04/2024
1	CalreticulinIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Sunscreening Agents (Sunscreens)IBA 04/2023
1	AcetylcholinesteraseIBA 01/2023
1	TachykininsIBA 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	enzalutamideIBA 01/2021
1	AndrogensIBA 01/2021
1	AntigensIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Dihydrotestosterone (Androstanolone)IBA 01/2021
1	SteroidsIBA 01/2021
1	Praziquantel (Biltricide)FDA Link 11/2020
1	RhodiumIBA 10/2020
1	Sulfhydryl Compounds (Thiols)IBA 10/2020
1	Doxycycline (Periostat)FDA LinkGeneric 07/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020
1	Antiviral Agents (Antivirals)IBA 10/2019
1	LigandsIBA 10/2019
1	Anaphylatoxin C5a ReceptorIBA 10/2019
1	Complement C5a (Complement 5a)IBA 10/2019
1	Antiparasitic Agents (Antiparasitics)IBA 01/2019
1	benzonidazole (benznidazole)IBA 01/2019
1	LignansIBA 04/2018
1	epimethoxypiperitolIBA 04/2018
1	VenomsIBA 10/2017
1	Spider Venoms (Venom, Spider)IBA 10/2017
1	PolyaminesIBA 10/2017
1	EnzymesIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	trametinibIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017

Therapy/Procedure

15	Therapeutics 10/2022 - 05/2011
8	Drug Therapy (Chemotherapy) 05/2015 - 04/2004
2	Radiotherapy 06/2005 - 04/2004
1	Immunotherapy 10/2022
1	Castration 01/2021